Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolò Panini

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|March 13, 2024
Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient BackgroundMichela Chiappa, Federica Guffanti, Chiara Grasselli, et al.
Cancers|April 12, 2022
Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant <i>Brca1</i> Proficient and Deficient Murine Ovarian CellsMichela Chiappa, Federica Guffanti, Martina Anselmi, et al.
Neurobiology of Disease|October 5, 2016
Macrophages are essential for maintaining a M2 protective response early after ischemic brain injuryCarlo Perego, Stefano Fumagalli, Elisa R Zanier, et al.
European Journal of Cell Biology|August 16, 2014
Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) plays a role in cell cycle progression and cytoskeletal dynamicsDavide Rovina, Laura Fontana, Laura Monti, et al.
American Journal of Cancer Research|April 18, 2013
ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patientsFrancesca Ricci, Sergio Bernasconi, Luca Porcu, et al.
Frontiers in Oncology|August 1, 2022
Stable <i>CDK12</i> Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor TreatmentRosaria Chilà, Michela Chiappa, Federica Guffanti, et al.
Advanced Healthcare Materials|March 13, 2023
Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli-Responsive NanocagesMaría Sancho-Albero, Giorgio Facchetti, Nicolò Panini, et al.
IEEE Transactions on Nanobioscience|September 10, 2015
3D Silicon Microstructures: A New Tool for Evaluating Biological Aggressiveness of Tumor CellsGiuliano Mazzini, Francesca Carpignano, Salvatore Surdo, et al.
Molecular Neurodegeneration|August 11, 2018
Counteracting roles of MHCI and CD8<sup>+</sup> T cells in the peripheral and central nervous system of ALS SOD1<sup>G93A</sup> miceGiovanni Nardo, Maria Chiara Trolese, Mattia Verderio, et al.
Cellular and Molecular Life Sciences : CMLS|December 22, 2021
Contingent intramuscular boosting of P2XR7 axis improves motor function in transgenic ALS micePaola Fabbrizio, Jessica D'Agostino, Cassandra Margotta, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|March 13, 2024
Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient BackgroundMichela Chiappa, Federica Guffanti, Chiara Grasselli, et al.
Cancers|April 12, 2022
Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant <i>Brca1</i> Proficient and Deficient Murine Ovarian CellsMichela Chiappa, Federica Guffanti, Martina Anselmi, et al.
Neurobiology of Disease|October 5, 2016
Macrophages are essential for maintaining a M2 protective response early after ischemic brain injuryCarlo Perego, Stefano Fumagalli, Elisa R Zanier, et al.
European Journal of Cell Biology|August 16, 2014
Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) plays a role in cell cycle progression and cytoskeletal dynamicsDavide Rovina, Laura Fontana, Laura Monti, et al.
American Journal of Cancer Research|April 18, 2013
ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patientsFrancesca Ricci, Sergio Bernasconi, Luca Porcu, et al.
Frontiers in Oncology|August 1, 2022
Stable <i>CDK12</i> Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor TreatmentRosaria Chilà, Michela Chiappa, Federica Guffanti, et al.
Advanced Healthcare Materials|March 13, 2023
Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli-Responsive NanocagesMaría Sancho-Albero, Giorgio Facchetti, Nicolò Panini, et al.
IEEE Transactions on Nanobioscience|September 10, 2015
3D Silicon Microstructures: A New Tool for Evaluating Biological Aggressiveness of Tumor CellsGiuliano Mazzini, Francesca Carpignano, Salvatore Surdo, et al.
Molecular Neurodegeneration|August 11, 2018
Counteracting roles of MHCI and CD8<sup>+</sup> T cells in the peripheral and central nervous system of ALS SOD1<sup>G93A</sup> miceGiovanni Nardo, Maria Chiara Trolese, Mattia Verderio, et al.
Cellular and Molecular Life Sciences : CMLS|December 22, 2021
Contingent intramuscular boosting of P2XR7 axis improves motor function in transgenic ALS micePaola Fabbrizio, Jessica D'Agostino, Cassandra Margotta, et al.
Pageof 4